Anna completed her PhD in antibody generation and nanomedicine for cancer therapeutics in Queen’s University Belfast in 2021, in collaboration with Fusion Antibodies Ltd., a Northern Irish antibody generation and engineering company. Prior to this she graduated from Trinity College Dublin in 2017 with a B.A. (Hons) in Natural Sciences, specialising in Molecular Medicine. She joined ValitaCell in 2021 as a product development scientist developing high-throughput solutions for measuring process analytics in bioprocessing.